With this clearer focus on the molecular details, these authors suggest TRPV6 activity is a survival response of at least three prostate cancer cell lines (LNCaP, PC-3 and DU 145) implicating a sensitivity to and requirement of increased intracellular calcium transients compared to normal tissue in the cancer phenotype. Here, TRPV6 is linked to prostate cancer.